Moreover, lower expression of PMEPA1-b indicated prostate cancer aggressiveness, including lower progression free survival (PFS) rates (p = 0.014) and overall survival (OS) rates (p < 0.01) (Figure 3B,C). This evidence concerns the gene PMEPA1 and prostate carcinoma.